Treatment of hepatitis C virus (HIV) C型肝炎 in Taiwan

2025 04 21 Owen Yang

Anti-virals for Hepatitis C virus (HCV) infections (#J05AP) was initially prescribed under the National Health Insurance since 2003 as an Interferon (#L03AB) -based therapy, which can be with or without ribavirin as the main antiviral, and this was only used in patients with evidence of liver fibrosis. In 2017 this was replaced with other high efficacy oral Direct Acting Antivirals for HCV, and is available for anyone who has a detectable level of HCV. More infomation can be found here.